期刊文献+

淫羊藿苷和淫羊藿次苷Ⅱ对内皮细胞eNOS表达和NOS活性的影响 被引量:15

Effects of icariin and icarisideⅡon eNOS expression and NOS activity in porcine aorta endothelial cells
下载PDF
导出
摘要 目的:用过表达表皮生长因子受体(epidermal growth factor receptor,EGFR)的猪动脉内皮细胞(porcineaorta endothelial,PAE)作为研究对象,探讨淫羊藿苷(icariin)和淫羊藿次苷Ⅱ(icarisideⅡ)对PAE中内皮型一氧化氮合酶(endothelial nitric oxide synthase,eNOS)表达和一氧化氮合酶(nitric oxide sythase,NOS)活性的影响及其可能机制。方法:利用PAE中转染EGFR并筛选稳定株,分别用12.5μmol/L的淫羊藿苷和淫羊藿次苷Ⅱ处理PAE和PAE-EGFR细胞48 h,观察各组细胞eNOS的表达变化;另在淫羊藿苷或淫羊藿次苷Ⅱ处理PAE和PAE-EGFR细胞时,分别加入表皮生长因子(epidermal growth factor,EGF)共同处理细胞,观察各组细胞eNOS的表达变化;检测淫羊藿苷和淫羊藿次苷Ⅱ处理前后PAE和PAE-EGFR细胞NOS的酶活性改变,并以西地那非作为对照。结果:Western blot显示PAE-EGFR细胞表达eNOS的基础值要比PAE细胞高,淫羊藿苷和淫羊藿次苷Ⅱ处理时PAE和PAE-EGFR细胞株中都能引起eNOS表达增加,并且在PAE-EGFR稳定株中eNOS的表达量比PAE细胞明显提高(P<0.01);在表达EGFR的PAE-EGFR细胞中,当淫羊藿次苷Ⅱ的浓度达到10-8 mol/L时,NOS活性增加到(15.37±1.49)u/mg,比PAE细胞高4.66 u/mg。在药物浓度达到10-7,10-6和10-5 mol/L时,淫羊藿次苷Ⅱ对PAE-EGFR细胞NOS活性的影响较PAE细胞显著增加(P<0.01);淫羊藿苷也能增加PAE和PAE-EGFR细胞的NOS酶活性,但是其效果比较淫羊藿次苷Ⅱ组平均低20%,而西地那非没有显著影响NOS酶活性。结论:淫羊藿苷和淫羊藿次苷Ⅱ可上调PAE和PAE-EGFR细胞eNOS的表达和提高NOS活性,对血管内皮细胞功能可能具有改善作用,而且淫羊藿次苷Ⅱ的效果优于淫羊藿苷,其作用机制可能与激活PAE细胞的EGF-EGFR信号通路有关。 Objective: To investigate the effects of icariin and icarisideⅡon eNOS expression and NOS activity in endothelial cells and possible mechanisms using EGFR over-expressed porcine aorta endothelial(PAE) cell line.Methods: The EGFR gene was transfected into PAE cells and genetic stable cell line(PAE-EGFR) was selected.12.5 μmol/L of icariin and of icarisideⅡwere used to treat the PAE and PAE-EGFR cells respectively for 48 h,the eNOS expression in each group was observed.EGF was also used to treat the cells to observe the regulatory effects of icariin and icarisideⅡon NOS activity.The re-gulatory effects of icariin and icarisideⅡon NOS activity were also observed,and sildenafil was used as a control.Results: Western blot showed that the basic value of eNOS expression was higher in PAE-EGFR group compared with that in PAE group,both of icariin and icarisideⅡincreased the eNOS expression in PAE and PAE-EGFR group(P〈0.01),and the value of eNOS expression was higher in PAE-EGFR group than that in PAE group.In the PAE-EGFR cell line,the NOS activity reached(15.37±1.49) u/mg when the concentration of icarisideⅡwas 10^-8 mol/L,which was 4.66 u/mg more than that in the PAE cell line.When the concentration reached 10^-7,10^-6 or 10^-5 mol/L,the change of NOS activity in PAE-EGFR group was greater than that in PAE group(P0.01).icariin also increased the NOS activity in PAE and PAE-EGFR cells,but the activity was 20% lower compared with icarisideⅡgroup,howe-ver,Sildenafil showed no influence on NOS activity.Conclusion: Icariin and icarisideⅡ may increase the eNOS expression through activating EGF-EGFR pathway in PAE cell,by which endothelial cells function could be regulated and the better effect was noted in icarisideⅡcompared to icariin.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2011年第4期500-504,共5页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(30972993)资助~~
关键词 淫羊藿苷 淫羊藿次苷 一氧化氮合酶 内皮细胞 受体 表皮生长因子 Icariin Sildenafil Nitric oxide synthase Endothelial cells Receptor epidermal growth factor
  • 相关文献

参考文献4

二级参考文献50

  • 1田龙,辛钟成,刘武江,袁亦铭,刘刚,陈亮,付杰,王玲珑.淫羊藿苷对动脉性ED模型大鼠阴茎海绵体压力和一氧化氮合酶亚型表达的影响[J].中华医学杂志,2004,84(11):954-957. 被引量:23
  • 2BaradaJH,MckimmyRM.Vasoactivepharmacotherapy. . 1994
  • 3ArmstrongDK,ConveryA,DinsmoreWW.Intracavernosalpapaverineandphentolamineforthemedicalmanagementoferectildysfunctioninagenitourinaryclinic. IntJSTDAIDS . 1993
  • 4McMahonCG.Acomparisonoftheresponsetotheintracavernousinjectionofacombinationofpapaverineandphentolamine ,prostaglandineE1 ,andacombinationofallthreeagentsinthemanagementofimpotence. IntJImpotRes . 1991
  • 5MUSEPackageInsert. . 1996
  • 6Borges FD.A new approach to the pharmacologic treatment of impotence. International Journal of Impotence Research . 1994
  • 7Kim ED,el-Rashidy R,McVary KT.Papaverine topical gel for treatment of erectile dysfunction. Journal d Urologie . 1995
  • 8Padma-Nathan H,Hellstrom WJ,Kaiser FE,et al.Treatment of men with erectile dysfunction with transurethral alprostadil.Medicated Urethral System for Erection ( MUSE ) Study Group[comments]. The New England Journal of Medicine . 1997
  • 9Costabile RA,Spevak M,Fishman IJ,et al.Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. Journal d Urologie . 1998
  • 10Engel JD,McVary KT.Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. Urology . 1998

共引文献55

同被引文献240

引证文献15

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部